Diagnamed Holdings Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	0.16	0.61	1.57	2.36
Cash & Short-Term Investments	0.16	0.61	1.57	2.36
Cash Growth	-73.29%	-61.35%	-33.40%	-
Other Receivables	0.03	0.06	0.05	0.03
Receivables	0.03	0.06	0.05	0.03
Prepaid Expenses	0.01	-	-	-
Total Current Assets	0.2	0.66	1.62	2.39
Total Assets	0.2	0.66	1.62	2.39
Accounts Payable	0.46	0.42	0.36	0.15
Accrued Expenses	0	0	0.01	-
Total Current Liabilities	0.47	0.43	0.37	0.15
Total Liabilities	0.47	0.43	0.37	0.15
Common Stock	3.57	3.57	3.17	3.11
Additional Paid-In Capital	1.03	1.03	0.15	0.01
Retained Earnings	-4.86	-4.36	-3.08	-1.95
Comprehensive Income & Other	-	-	1	1.06
Shareholders' Equity	-0.27	0.24	1.25	2.24
Total Liabilities & Equity	0.2	0.66	1.62	2.39
Net Cash (Debt)	0.16	0.61	1.57	2.36
Net Cash Growth	-73.29%	-61.35%	-33.40%	-
Net Cash Per Share	0.00	0.01	0.02	0.04
Filing Date Shares Outstanding	80.05	80.05	76.22	76.22
Total Common Shares Outstanding	80.05	80.05	76.22	75.6
Working Capital	-0.27	0.24	1.25	2.24
Book Value Per Share	-0.00	0.00	0.02	0.03
Tangible Book Value	-0.27	0.24	1.25	2.24
Tangible Book Value Per Share	-0.00	0.00	0.02	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.